Protein structural defects enable pharmaceutical targeting while functionalizing the M2 proton channel
2019 ◽
Vol 514
(1)
◽
pp. 86-91
2005 ◽
Vol 89
(4)
◽
pp. 2402-2411
◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 27
(2)
◽
pp. 160-167
◽
Keyword(s):
2012 ◽
Vol 12
(10)
◽
pp. 971-978
◽
Keyword(s):